Home
ESLA
ESLA News

Latest Estrella Immunopharma Inc. (ESLA) News on October 31, 2025

Estrella Immunopharma Regains Compliance with Nasdaq Listing Requirements

Business Wire

25 days ago

Estrella Immunopharma Regains Compliance with Nasdaq Listing Requirements

Estrella Immunopharma Announces Activation of Additional Site for Phase I/II STARLIGHT-1 Trial in B-cell Non-Hodgkin’s Lymphoma

Business Wire

5 months ago

Estrella Immunopharma Announces Activation of Additional Site for Phase I/II STARLIGHT-1 Trial in B-cell Non-Hodgkin’s Lymphoma

Estrella Immunopharma Announces Approximately $3.35 Million Private Placement Equity Financing

Business Wire

5 months ago

Estrella Immunopharma Announces Approximately $3.35 Million Private Placement Equity Financing

Estrella Immunopharma Initiates Second Cohort and Doses First Patient in STARLIGHT-1 Trial of EB103 in Advanced B-Cell Non-Hodgkin’s Lymphomas

Business Wire

5 months ago

Estrella Immunopharma Initiates Second Cohort and Doses First Patient in STARLIGHT-1 Trial of EB103 in Advanced B-Cell Non-Hodgkin’s Lymphomas

Estrella Immunopharma, Inc. (NASDAQ: ESLA) Receives Buy Rating With a Price Target of $14.00 From CB Capital Partners

Business Wire

8 months ago

Estrella Immunopharma, Inc. (NASDAQ: ESLA) Receives Buy Rating With a Price Target of $14.00 From CB Capital Partners

Estrella Immunopharma completes first dose cohort in STARLIGHT trial

TipRanks

8 months ago

Estrella Immunopharma completes first dose cohort in STARLIGHT trial

Estrella Immunopharma Completes First Dose Cohort in STARLIGHT-1 Trial and Receives Approval to Initiate Higher Dose Cohort

Business Wire

8 months ago

Estrella Immunopharma Completes First Dose Cohort in STARLIGHT-1 Trial and Receives Approval to Initiate Higher Dose Cohort

Estrella Immunopharma, Inc. (NASDAQ: ESLA; ESLAW) Receives Buy Rating with a 12-Month Price Target of $16.00 from D. Boral Capital

Business Wire

8 months ago

Estrella Immunopharma, Inc. (NASDAQ: ESLA; ESLAW) Receives Buy Rating with a 12-Month Price Target of $16.00 from D. Boral Capital

Spotlight On US Penny Stocks: Estrella Immunopharma And Two Others To Consider

Simply Wall St.

a year ago

Spotlight On US Penny Stocks: Estrella Immunopharma And Two Others To Consider

Estrella Immunopharma Achieves Complete Response in First Patient Treated with CD19- Redirected ARTEMIS® T-cells

Business Wire

a year ago

Estrella Immunopharma Achieves Complete Response in First Patient Treated with CD19- Redirected ARTEMIS® T-cells

Estrella Immunopharma Announces Appointment of Hong Zhang as Chairperson and Board Member

Business Wire

a year ago

Estrella Immunopharma Announces Appointment of Hong Zhang as Chairperson and Board Member

Vaxxinity, UF Join Forces Against Neurodegenerative Diseases

Exec Edge

2 years ago

Vaxxinity, UF Join Forces Against Neurodegenerative Diseases

Investors Met With Slowing Returns on Capital At PermRock Royalty Trust (NYSE:PRT)

Simply Wall St.

2 years ago

Investors Met With Slowing Returns on Capital At PermRock Royalty Trust (NYSE:PRT)

3 Penny Stocks AI Predicts Will Skyrocket 10,000%

InvestorPlace

2 years ago

3 Penny Stocks AI Predicts Will Skyrocket 10,000%

Evolution (EPM) Expands Asset Base, Signs $43.5M Contract

Zacks

2 years ago

Evolution (EPM) Expands Asset Base, Signs $43.5M Contract

7 A-Rated Semiconductor Stocks to Buy in January

InvestorPlace

2 years ago

7 A-Rated Semiconductor Stocks to Buy in January

Tevogen Bio Inc. and Semper Paratus Acquisition Corporation Announce Effectiveness of Registration Statement for Business Combination

GlobeNewswire

2 years ago

Tevogen Bio Inc. and Semper Paratus Acquisition Corporation Announce Effectiveness of Registration Statement for Business Combination

Adicet Bio to Host Conference Call to Provide Updates on its Clinical Pipeline and Corporate Outlook

Business Wire

2 years ago

Adicet Bio to Host Conference Call to Provide Updates on its Clinical Pipeline and Corporate Outlook

Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) has caught the attention of hedge funds investors who hold a sizeable 28% stake

Simply Wall St.

2 years ago

Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) has caught the attention of hedge funds investors who hold a sizeable 28% stake

The Container Store promotes two execs to foster custom services, brick-and-mortar expansion

Retail Dive

2 years ago

The Container Store promotes two execs to foster custom services, brick-and-mortar expansion

Stronghold Enters Into $15 Million Private Placement

GlobeNewswire

2 years ago

Stronghold Enters Into $15 Million Private Placement

The Central and Eastern Europe Fund, Inc., The European Equity Fund, Inc., and The New Germany Fund, Inc. Make Yearly Distribution Announcements

Business Wire

2 years ago

The Central and Eastern Europe Fund, Inc., The European Equity Fund, Inc., and The New Germany Fund, Inc. Make Yearly Distribution Announcements

3 Moonshot Stocks to Invest in the Future of Space Exploration

InvestorPlace

2 years ago

3 Moonshot Stocks to Invest in the Future of Space Exploration

Codexis, Inc. (NASDAQ:CDXS) Stock Rockets 41% But Many Are Still Ignoring The Company

Simply Wall St.

2 years ago

Codexis, Inc. (NASDAQ:CDXS) Stock Rockets 41% But Many Are Still Ignoring The Company

Insider Sell Alert: EVP Scott Schatz Sells 11,729 Shares of Townsquare Media Inc (TSQ)

GuruFocus.com

2 years ago

Insider Sell Alert: EVP Scott Schatz Sells 11,729 Shares of Townsquare Media Inc (TSQ)

Urban One Inc (UONE) Reports Mixed Results for First and Second Quarters of 2023

GuruFocus.com

2 years ago

Urban One Inc (UONE) Reports Mixed Results for First and Second Quarters of 2023

3 Wind Stocks to Buy for a Sustainable and Profitable Future

InvestorPlace

2 years ago

3 Wind Stocks to Buy for a Sustainable and Profitable Future

PR Newswire

2 years ago

APX Acquisition Corp. I & Bioceres Group Announce Letter of Intent for a Business Combination with a Precision Medicine Diagnostic and Wellness Services Company

Immix Biopharma to Present at the 2023 JMP Securities Hematology and Oncology Summit

GlobeNewswire

2 years ago

Immix Biopharma to Present at the 2023 JMP Securities Hematology and Oncology Summit

Penny Stock Powerhouses: 7 Picks Poised for Explosive Growth

InvestorPlace

2 years ago

Penny Stock Powerhouses: 7 Picks Poised for Explosive Growth

Investors Don't See Light At End Of CPI Card Group Inc.'s (NASDAQ:PMTS) Tunnel

Simply Wall St.

2 years ago

Investors Don't See Light At End Of CPI Card Group Inc.'s (NASDAQ:PMTS) Tunnel

Associated Press Finance

2 years ago

Best: Q3 Earnings Snapshot

BEST Inc. Announces Unaudited Third Quarter 2023 Financial Results

PR Newswire

2 years ago

BEST Inc. Announces Unaudited Third Quarter 2023 Financial Results

APx Acquisition Corp. I (NASDAQ:APXI) most popular amongst private companies who own 39% of the shares, institutions hold 38%

Simply Wall St.

2 years ago

APx Acquisition Corp. I (NASDAQ:APXI) most popular amongst private companies who own 39% of the shares, institutions hold 38%

GALIANO GOLD REPORTS Q3 2023 OPERATING AND FINANCIAL RESULTS

PR Newswire

2 years ago

GALIANO GOLD REPORTS Q3 2023 OPERATING AND FINANCIAL RESULTS

Siebert Reports Third Quarter 2023 Financial Results

Business Wire

2 years ago

Siebert Reports Third Quarter 2023 Financial Results

Shareholders in Westport Fuel Systems (TSE:WPRT) are in the red if they invested three years ago

Simply Wall St.

2 years ago

Shareholders in Westport Fuel Systems (TSE:WPRT) are in the red if they invested three years ago

Associated Press Finance

2 years ago

Adverum Biotechnologies: Q3 Earnings Snapshot

Adverum Biotechnologies Reports Third Quarter 2023 Financial Results and Pipeline Highlights

GlobeNewswire

2 years ago

Adverum Biotechnologies Reports Third Quarter 2023 Financial Results and Pipeline Highlights

ProPhase Labs Announces Financial Results for the Three Months Ended September 30, 2023

GlobeNewswire

2 years ago

ProPhase Labs Announces Financial Results for the Three Months Ended September 30, 2023

Share on Social Networks: